397 related articles for article (PubMed ID: 2441877)
1. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor.
Lasky LA; Nakamura G; Smith DH; Fennie C; Shimasaki C; Patzer E; Berman P; Gregory T; Capon DJ
Cell; 1987 Sep; 50(6):975-85. PubMed ID: 2441877
[TBL] [Abstract][Full Text] [Related]
2. Effects of anti-gp120 monoclonal antibodies on CD4 receptor binding by the env protein of human immunodeficiency virus type 1.
Linsley PS; Ledbetter JA; Kinney-Thomas E; Hu SL
J Virol; 1988 Oct; 62(10):3695-702. PubMed ID: 2458487
[TBL] [Abstract][Full Text] [Related]
3. Epitope mapping of the human immunodeficiency virus type 1 gp120 with monoclonal antibodies.
Dowbenko D; Nakamura G; Fennie C; Shimasaki C; Riddle L; Harris R; Gregory T; Lasky L
J Virol; 1988 Dec; 62(12):4703-11. PubMed ID: 2460639
[TBL] [Abstract][Full Text] [Related]
4. A soluble recombinant polypeptide comprising the amino-terminal half of the extracellular region of the CD4 molecule contains an active binding site for human immunodeficiency virus.
Berger EA; Fuerst TR; Moss B
Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2357-61. PubMed ID: 2451247
[TBL] [Abstract][Full Text] [Related]
5. A rapid solution immunoassay to quantify binding of the human immunodeficiency virus envelope glycoprotein to soluble CD4.
McQuade TJ; Pitts TW; Tarpley WG
Biochem Biophys Res Commun; 1989 Aug; 163(1):172-6. PubMed ID: 2549987
[TBL] [Abstract][Full Text] [Related]
6. Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack.
Lyerly HK; Matthews TJ; Langlois AJ; Bolognesi DP; Weinhold KJ
Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4601-5. PubMed ID: 3037522
[TBL] [Abstract][Full Text] [Related]
7. Certain human Gp120-HIV antibodies react with anti-CD4 antibodies.
Lundin K; Karlsson A; Nygren A; Löfström A; Gigliotti D; Wigzell H
Scand J Immunol; 1988 Jan; 27(1):113-7. PubMed ID: 2829345
[TBL] [Abstract][Full Text] [Related]
8. Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion.
Matthews TJ; Weinhold KJ; Lyerly HK; Langlois AJ; Wigzell H; Bolognesi DP
Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5424-8. PubMed ID: 3037551
[TBL] [Abstract][Full Text] [Related]
9. The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4.
Landau NR; Warton M; Littman DR
Nature; 1988 Jul; 334(6178):159-62. PubMed ID: 3260352
[TBL] [Abstract][Full Text] [Related]
10. Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis.
Fenouillet E; Clerget-Raslain B; Gluckman JC; Guétard D; Montagnier L; Bahraoui E
J Exp Med; 1989 Mar; 169(3):807-22. PubMed ID: 2538547
[TBL] [Abstract][Full Text] [Related]
11. Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of the CD4 molecule defined by site-directed mutagenesis.
Mizukami T; Fuerst TR; Berger EA; Moss B
Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9273-7. PubMed ID: 2461565
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to CD4 in individuals infected with human immunodeficiency virus type 1.
Kowalski M; Ardman B; Basiripour L; Lu YC; Blohm D; Haseltine W; Sodroski J
Proc Natl Acad Sci U S A; 1989 May; 86(9):3346-50. PubMed ID: 2541442
[TBL] [Abstract][Full Text] [Related]
13. Characterization of CD4 glycoprotein determinant-HIV envelope protein interactions: perspectives for analog and vaccine development.
Farrar WL; Harel-Bellan A; Ferris DK
Crit Rev Immunol; 1988; 8(4):315-39. PubMed ID: 2850890
[TBL] [Abstract][Full Text] [Related]
14. Soluble CD4 molecules neutralize human immunodeficiency virus type 1.
Traunecker A; Lüke W; Karjalainen K
Nature; 1988 Jan; 331(6151):84-6. PubMed ID: 2829024
[TBL] [Abstract][Full Text] [Related]
15. Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120.
Dianzani U; Bragardo M; Buonfiglio D; Redoglia V; Funaro A; Portoles P; Rojo J; Malavasi F; Pileri A
Eur J Immunol; 1995 May; 25(5):1306-11. PubMed ID: 7539755
[TBL] [Abstract][Full Text] [Related]
16. The MHC-binding and gp120-binding functions of CD4 are separable.
Lamarre D; Ashkenazi A; Fleury S; Smith DH; Sekaly RP; Capon DJ
Science; 1989 Aug; 245(4919):743-6. PubMed ID: 2549633
[TBL] [Abstract][Full Text] [Related]
17. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding.
Clayton LK; Sieh M; Pious DA; Reinherz EL
Nature; 1989 Jun; 339(6225):548-51. PubMed ID: 2543930
[TBL] [Abstract][Full Text] [Related]
18. Generation and characterization of monoclonal antibodies to the putative CD4-binding domain of human immunodeficiency virus type 1 gp120.
Sun NC; Ho DD; Sun CR; Liou RS; Gordon W; Fung MS; Li XL; Ting RC; Lee TH; Chang NT
J Virol; 1989 Sep; 63(9):3579-85. PubMed ID: 2474670
[TBL] [Abstract][Full Text] [Related]
19. HIV infection is blocked in vitro by recombinant soluble CD4.
Fisher RA; Bertonis JM; Meier W; Johnson VA; Costopoulos DS; Liu T; Tizard R; Walker BD; Hirsch MS; Schooley RT
Nature; 1988 Jan; 331(6151):76-8. PubMed ID: 2829022
[TBL] [Abstract][Full Text] [Related]
20. Identification of the residues in human CD4 critical for the binding of HIV.
Arthos J; Deen KC; Chaikin MA; Fornwald JA; Sathe G; Sattentau QJ; Clapham PR; Weiss RA; McDougal JS; Pietropaolo C
Cell; 1989 May; 57(3):469-81. PubMed ID: 2541915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
